Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Portage Biotech Q2 Net Loss $2.9M

Portage Biotech (NASDAQ:PRTG) will report on Q2 2022.

byBill Haddad

November 23, 2021

1 minute read

Portage Biotech (NASDAQ:PRTG) will report on Q2 2022.

Fluidigm Reports Co-Marketing Deal With Ultivue For Biomarker Imaging Solutions For Precision Medicine, No Terms Disclosed

By Benzinga Newsdesk

Today, 2:58 AM

Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a co-marketing agreement with Ultivue, Inc., under which

FLDM

News

Ford CEO Says Ford Must Vertically Integrate “so Everyone Has A Role”; Says EVs Will Require 40% Less Labor To Build

By Benzinga Newsdesk

Today, 2:58 AM

- Reuters

Earnings

CrossAmerica Partners’s Return On Capital Employed Insights

By Benzinga Insights

Today, 2:58 AM

According to Benzinga Pro, during Q2, CrossAmerica Partners (NYSE:CAPL) earned $7.57 million, a 3602.31% increase from the preceding quarter. CrossAmerica Partners also posted a total of $859.33 million in sales, a 30.74% increase since Q1.

CAPL

View Q2 EPS $(0.39) Misses $(0.28) Estimate, Sales $16.00M Miss $22.70M Estimate

By Benzinga Newsdesk

Today, 2:58 AM

View (NASDAQ:VIEW) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.28) by 39.29 percent. The company reported quarterly sales of $16.00 million which missed the analyst

VIEW

Portage Biotech Q2 Net Loss $2.9M

Related Posts

Fluidigm Reports Co-Marketing Deal With Ultivue For Biomarker Imaging Solutions For Precision Medicine, No Terms Disclosed

Ford CEO Says Ford Must Vertically Integrate “so Everyone Has A Role”; Says EVs Will Require 40% Less Labor To Build

CrossAmerica Partners’s Return On Capital Employed Insights

View Q2 EPS $(0.39) Misses $(0.28) Estimate, Sales $16.00M Miss $22.70M Estimate